Latest News Archive

Please select Category, Year, and then Month to display items

Well done to Kovsies GradStar top 11!

08 October 2019 | Story Xolisa Mnukwa | Photo Charl Devenish

Gradstar UFS — The 2019 GradStar programme is all about producing well-rounded students and providing them with opportunities in the world of work, explained Head of UFS Career Services, Belinda Janeke.

Congratulations to the Kovsies top-11 students who made it into the GradStar top-100 programme for 2019!

Each year, 100 South African students are selected through a rigorous four-phase judging process to become part of the GradStar programme. The programme is designed to offer opportunities for employment to previously unrecognised students.

What makes the top 11?

According to the UFS Head of Career Services, Belinda Janeke, the GradStar programme is all about producing a well-rounded student. Approximately 6 000 applications were received from Kovsies, of which 500 were selected based on a personality test. Another test was given to the 500 students who passed the personality test, after which interviews were conducted to determine the top 100 from the UFS.

The students who were selected to represent the UFS exhibited the most potential as future leaders in their respective fields. Apart from academic achievement, contestants were evaluated according to their individual soft skills such as motivation, discipline, altruism, and attitude. This combination promised to deliver top candidates for future employers.

2019 GradStar programme experiences

Throughout the competition, Kovsie contestants were exposed to new people and opportunities to network with various companies in their preferred career fields, where they had the opportunity to share their CVs with potential employers. Contestants were also afforded the opportunity to develop critical problem-solving skills in the world of work. The GradStar top-100 students also have a WhatsApp group where jobs are advertised.

The programme was valuable for the Kovsies; not only did it prepare them for employment, but also provided them with an opportunity for learning and recognising their own strengths and weaknesses as individuals in the working world.

Congratulations to the Kovsies who made it into the GradStar top 100:

Mariné du Toit: Bachelor of Social Work
Nyiko Maluleka: Bachelor of Arts, Corporate and Marketing Communication
Bianca Malan: Bachelor of Accounting, Financial Accounting
Boitumelo Mancoe: Master of Business Administration
Kabelo Mashego: Bachelor of Medicine and Bachelor of Surgery (MB ChB)
Kananelo Moletsane: Bachelor of Agriculture
Mudzunga Mukwevho: Bachelor of Accounting, Financial Accounting
Neo Roberts: Bachelor of Science, Information Technology
Refilwe Maimane: Bachelor of Commerce, Accounting
Themba Makhoba: Bachelor of Public Administration
Mpolokeng Mmutle: Bachelor of Commerce, Accounting

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children

2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept